Education
About Us
Working with TipRanks
Follow Us
Terns Pharmaceuticals (TERN)
NASDAQ:TERN
Terns Pharmaceuticals (TERN) Ownership Overview
0.75% Insiders
9.54% Mutual Funds
52.97% Other Institutional Investors
9.87% ETFs
26.87% Public Companies and
Individual Investors
The ownership structure of Terns Pharmaceuticals (TERN) stock is a mix of institutional, retail, and individual investors. Approximately 72.37% of the company’s stock is owned by Institutional Investors, 0.75% is owned by Insiders, and 26.87% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 02, 2025 | xxxxxxxxxxxxx | $7401 | |
Jul 03, 2025 | xxxxxxxxxxxxx | $3634 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $39200 | |
Jun 16, 2025 | xxxxxxxxxxxxx | $57050 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Sep 30, 2025 | xxxxxxxxxxxxx | $182447 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $939921 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $2193333 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,687,251 | Institution | 4.09% | 83,184,383 | |
| 3,235,443 | Institution | 3.59% | 72,991,594 | |
| 3,107,563 | Institution | 3.45% | 70,106,621 | |
| 1,059,924 | Institution | 1.18% | 23,911,885 | |
| 875,849 | Institution | 0.97% | 19,759,153 | |
| 820,176 | Institution | 0.91% | 18,503,171 | |
| 763,486 | Institution | 0.85% | 17,224,244 | |
| 634,944 | Institution | 0.70% | 14,324,337 | |
| 476,190 | Insider | 0.53% | 10,742,846 | |
| 449,500 | Institution | 0.50% | 10,140,720 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,107,563 | Institution | 3.45% | 70,106,621 | |
| 1,059,924 | Institution | 1.18% | 23,911,885 | |
| 875,849 | Institution | 0.97% | 19,759,153 | |
| 820,176 | Institution | 0.91% | 18,503,171 | |
| 634,944 | Institution | 0.70% | 14,324,337 | |
| 449,500 | Institution | 0.50% | 10,140,720 | |
| 392,343 | Institution | 0.44% | 8,851,258 | |
| 338,167 | Institution | 0.38% | 7,629,048 | |
| 224,220 | Institution | 0.25% | 5,058,403 | |
| 171,768 | Institution | 0.19% | 3,875,086 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,383,621 | Institution | 2.65% | 17,900,994 | |
| 1,779,048 | Institution | 1.97% | 40,135,323 | |
| 691,693 | Institution | 0.77% | 5,194,614 | |
| 617,141 | Institution | 0.69% | 13,922,701 | |
| 458,671 | Institution | 0.51% | 10,347,618 | |
| 343,920 | Institution | 0.38% | 2,582,839 | |
| 328,282 | Institution | 0.36% | 7,406,042 | |
| 322,937 | Institution | 0.36% | 6,694,484 | |
| 257,861 | Institution | 0.29% | 5,345,459 | |
| 174,612 | Institution | 0.19% | 3,619,707 |
FAQ
Who Owns Terns Pharmaceuticals (TERN)?
According to the latest TipRanks data, approximately 52.97% of the company's stock is held by institutional investors, 0.75% is held by insiders, and 26.87% is held by retail investors.
What percentage of Terns Pharmaceuticals (TERN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 52.97% of Terns Pharmaceuticals (TERN) stock is held by institutional investors.
What percentage of Terns Pharmaceuticals (TERN) stock is held by retail investors?
According to the latest TipRanks data, approximately 26.87% of Terns Pharmaceuticals (TERN) stock is held by retail investors.
Who owns the most shares of Terns Pharmaceuticals (TERN)?
Vanguard owns the most shares of Terns Pharmaceuticals (TERN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.